Tenderwize
Retour à la recherche

Open-house rebate agreements for Betamethason and antibiotics

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 163 days left·Open·Supplies
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Betamethason und Antibiotika, ATC D07CC01

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

Submission by original documents is required and electronic submission is not allowed, which increases delivery and tim...

The buyer may later replace the open-house agreements with exclusive rebate agreements, causing automatic termination o...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 31, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive rebate agreements for pharmaceutical products with active substance Betamethason and antibiotics, ATC D07CC01.
  • Open-house model with uniform terms for all participants; no individual negotiations.
Afficher le résumé complet

This is an open-house pharmaceutical supply notice by AOK Rheinland-Pfalz/Saarland for non-exclusive rebate agreements on Betamethason and antibiotics (ATC D07CC01), with a 24-month maximum term and monthly entry possible. The notice explicitly states that it is not a public procurement contract under the procurement rules, but it is published for transparency. No contract value is provided. Submission is by original documents only; electronic submission is not allowed. The notice excludes medicines listed as children’s medicines under the BfArM list (§ 35 Abs. 5a SGB V).

Risques

Submission by original documents is required and electronic submission is not allowed, which increases delivery and tim...

The buyer may later replace the open-house agreements with exclusive rebate agreements, causing automatic termination o...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Only authorised and marketable medicines in Germany may be supplied.

Administrative

  • If a medicine is not yet listed in Lauer-Taxe at submission time, an AMIce public extract must be provided with the required information.
  • If the AMIce extract is incomplete or outdated, supplementary evidence such as approval documents, change notifications, or an affidavit must be submitted.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreements for Betamethason and antibiotics

Single lot open-house model for non-exclusive rebate agreements for medicines with the stated active substance/ATC D07CC01. The contracting buyer offers the same conditions to all interested pharmaceutical companies, with no individual negotiations. Contracts can start on the first day of each month within the 24-month period, earliest 2025-06-01, and end no later than 24 months after the earliest start date. The notice says the buyer may replace these open-house agreements with exclusive agreements later. Medicines listed as children’s medicines under the BfArM list are excluded. Eligibility-related supply proof is required for marketed medicines in Germany.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 31, 2027

Détails de la procédure

Date de publication
10 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
237226-2025

Documents (1)

Appels d'offres similaires